Member Info for Uncanny

Agree blade, l am sitting put. I think both VAL and EHGO know where we are going in the next +12 months. Don’t forget that despite the penalties, EHGO could also lose money but have carefully assessed the risk / reward.

Obviously not happy one bit with dilution, but looking at the terms again as long as VALs compounds meet their targets then l can live with it if you believe in the science and that they are commercial. The 213mn subscription shares is a given, its done and we have faced that dilution already which IMHO is now priced at 0.4 or 20% drop on Friday. They had no choice. The warrants and CLN’s are an OPTION and this is how l read it. The warrant exercise is over a 5 year period on total commitments and CLN’s can only be exercised after 12 months of each tranche issuance again over 5 years There wii be a minimum of 8 tranches so VAL receive a further £1.75mn cash on drawdown (they can freeze auto drawdown), BEFORE any exercise can occur after June, so no further dilution until l’d say after July 2020 or thereafter depending on when the first CLN tranche is issued. Also there is no interest payable, so funding cost for VAL. Lets assume VAL don’t need any more money then after the 8 tranches and warrant exercise they will have received circa £3.5mn in monies or 2 to 3 years of funding. The conversion has to be at 20% premium to the lowest bid. Will the facility go through and so not trigger a break fee - yes l believe because EHGO just have 213mn new shares and without the funding VAL can’t really continue unless they have alternative financing or a plan B. It has too. Discount the 213mn shares and ask yourself what value enhancing news are we going to get in the next minimum 13 months before any further dilution? Where could the price be and what milestones would we have achieved, what deals tied up and for how much? EHGO are an investor - they will make much more money from the success if VAL through a shareholding. Yes they make on break fees etc, but if anyone has bought a house upfront fees, penalties are very normal. VAL have just bought themselves time and upon successful deals with 401 and potentially 201 early, any future dilution could be swallowed up by our higher market cap which should be be for a CTII company IMHO be north of £25mn. All IMHO and DYOR My perspective.

No insult was intended. I just was considering when we 8 bagged back in Dec 2017 with 401 news - that would have been the same at todays level of over 3p. 201 could well do that when we get the results through or heres hoping so!

Thats not too bad - are you going to the AGM? 201 is the key to the success of VAL imho.

Good honest post Freddy. What is your average price if you don’t mind me asking? The frustrating part for me is had they done a EHGO deal with longer term financing earlier, we could well have been at a completely different and higher share price level today. Trickey’s post shows how EHGO should not be written off as they have genuinely helped many companies get back on their feet. The results thus far for 201, 301 and 401 are superbly encouraging but need to convert in to pounds and pence or at least know what to expect. As you say it is detail that we need and l suspect we may get something before the AGM as a sweetner.

Nice to get some balanced informative posts, albeit l have so many on filter now l hardly ever see probably more than 5 posters now, LOL.

Why did you say that Trickey?

As the RNS states - from “a position of strength” but the full extent of the facility does not need to be utilised as you say and cancelled like the other companies t Tricky mentioned that had used EHGO.

Yes but the updated text and timeline is from 25th April 2019, which suggest 301 pre clinical now complete, so hopefully update soon plus 201 news EO CTl/ll and more on 401 deal to follow hopefully. Combined with the recent funding, VAL all looks set to flourish. I like Dr Halls inference on the share price “blue sky” and Pl’s title: “Valirx primed for a pivotal year”

Dracula - yes it is to start of 301 CT and suggest pre-CT now complete. I did like the bit that says they have received “significant interest” for 401 from partners.

Don’t understand what you are say 3 v 1

Only 1 mm left at .45 then up to .50 we go.

Lol , Rambo. We are blue and all buys so far. Calm after the storm in a teacup!

Freddie - desperation my friend and don’t hold your breath for any apologies. After Fridays RNS, its not going quite as planned as they expected to short the pants out of VAL, but they have been faced by a constant wall of buying! As said previously, VAL have the money to continue now for several years, see the compounds to fruition and more importantly, commercialise from junior bio to cash cow. Over and out!

http://tools.euroland.com/tools/PressReleases/GetPressRelease/?ID=3602581&lang=en-GB&companycode=services

No Taverham, read it again please. Gone from 3.78% to 3%. Obviously de-risked to take account for the 20% subscription shares. Have you seen a 25mn share sell? No

Comforting to see all the large trades were buys and sells were scrappy. Panicking out PI’s scared by the unscrupulous shorters with their hard earned money - disgraceful! ;@)

Rollocks Cock Russell! NS has seen his holding go down to 80% losing 20% to the 20% subscription shares. Has anyone seen a sale go through at over 25,000,000 shares? Nope? Me neither!

They are just desperate because the share price is holding it own and people are buying. Funny really, why? We have the money, we have the commercial science.

I should have said shares in issue not mkt cap.